Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1992Journal of Biological ChemistryOpen Access

The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors.

View Full Paper
Ask AI
Bookmark
Share

Authors

DRDavid M. RothsteinUPMC Health SystemHSHirohisa SaitoNihon UniversityMSMichel StreuliOSE Immunotherapeutics (France)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rothstein et al. (1992) studied this question.

synapsesocial.com/papers/6a1a53ca7f49d245439bbcfehttps://doi.org/10.1016/s0021-9258(19)50549-x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The role of the mammalian branchpoint sequence in pre-mRNA splicing.1988 · 214 citations
  2. 2Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains dfffering in the number of internal repeats1984 · 219 citations
  3. 3Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene.1991 · 186 citations
  4. 4Transitions from high to low molecular weight isoforms of CD45 (T200) involve rapid activation of alternate mRNA splicing and slow turnover of surface CD45R.1989 · 70 citations
  5. 5Complete exon-intron organization of the human leukocyte common antigen (CD45) gene.1988 · 106 citations